source
- Pfizer shuts India cancer drug plant for up to two years, worsening drug shortagesPfizer has temporarily closed a manufacturing site in India that produces several cancer medicines. The company says the facility will remain idle for as long as two years while it addresses the i…
- Formation Bio raises $600 million fund to expand AI-driven drug licensing and testing modelFormation Bio, an AI-focused biotech that builds value by acquiring external drug assets, developing them and then transferring them to partners, announced a new financing round. The company secur…